- Home
- LPSN vs STRO Comparison
LPSN vs STRO Comparison
Compare LPSN & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- STRO
- Stock Information
- Founded
- LPSN 1995
- STRO 2003
- Country
- LPSN United States
- STRO United States
- Employees
- LPSN N/A
- STRO N/A
- Industry
- LPSN EDP Services
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LPSN Technology
- STRO Health Care
- Exchange
- LPSN Nasdaq
- STRO Nasdaq
- Market Cap
- LPSN 84.5M
- STRO 76.5M
- IPO Year
- LPSN 2000
- STRO 2018
- Fundamental
- Price
- LPSN $0.54
- STRO $0.86
- Analyst Decision
- LPSN Hold
- STRO Hold
- Analyst Count
- LPSN 1
- STRO 7
- Target Price
- LPSN N/A
- STRO $1.97
- AVG Volume (30 Days)
- LPSN 5.8M
- STRO 436.1K
- Earning Date
- LPSN 11-06-2025
- STRO 11-12-2025
- Dividend Yield
- LPSN N/A
- STRO N/A
- EPS Growth
- LPSN N/A
- STRO N/A
- EPS
- LPSN N/A
- STRO N/A
- Revenue
- LPSN $271,750,000.00
- STRO $104,473,000.00
- Revenue This Year
- LPSN N/A
- STRO $65.48
- Revenue Next Year
- LPSN N/A
- STRO N/A
- P/E Ratio
- LPSN N/A
- STRO N/A
- Revenue Growth
- LPSN N/A
- STRO N/A
- 52 Week Low
- LPSN $0.50
- STRO $0.52
- 52 Week High
- LPSN $2.08
- STRO $4.60
- Technical
- Relative Strength Index (RSI)
- LPSN 31.20
- STRO 45.34
- Support Level
- LPSN $0.52
- STRO $0.84
- Resistance Level
- LPSN $0.60
- STRO $0.95
- Average True Range (ATR)
- LPSN 0.05
- STRO 0.06
- MACD
- LPSN -0.00
- STRO -0.01
- Stochastic Oscillator
- LPSN 16.38
- STRO 19.04
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.